|
WHAMM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.385000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.979700E-03 |
| Normal-vs-Stage2 |
9.975500E-02 |
| Normal-vs-Stage3 |
9.416500E-03 |
| Normal-vs-Stage4 |
2.871900E-02 |
| Stage1-vs-Stage2 |
9.511000E-01 |
| Stage1-vs-Stage3 |
5.762600E-01 |
| Stage1-vs-Stage4 |
7.677600E-01 |
| Stage2-vs-Stage3 |
7.833800E-01 |
| Stage2-vs-Stage4 |
8.810000E-01 |
| Stage3-vs-Stage4 |
9.042000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.202600E-03 |
| Normal-vs-AfricanAmerican |
9.746400E-01 |
| Normal-vs-Asian |
1.591610E-01 |
| Caucasian-vs-AfricanAmerican |
1.022220E-01 |
| Caucasian-vs-Asian |
5.301400E-01 |
| AfricanAmerican-vs-Asian |
3.086400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.960100E-02 |
| Normal-vs-Female |
2.457200E-03 |
| Male-vs-Female |
4.208600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.362200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.446100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.937600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.003680E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.917800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.652600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.139600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.031400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.091000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.742600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.713800E-01 |
| Classical-VS-Follicular |
2.041000E-01 |
| Classical-VS-Other |
5.679400E-01 |
| Classical-VS-Normal |
5.837500E-02 |
| Tall-VS-Follicular |
9.338200E-01 |
| Tall-VS-Other |
9.065400E-01 |
| Tall-VS-Normal |
2.003600E-02 |
| Follicular-VS-Other |
9.580400E-01 |
| Follicular-VS-Normal |
8.659300E-03 |
| Other-VS-Normal |
1.292590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.644600E-03 |
| Normal-vs-N1 |
3.162200E-02 |
| N0-vs-N1 |
6.343000E-01 |
|
|
